Company & Sponsor Intelligence
Centre Hospitalier Universitaire Dijon
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials5
Recruiting3
Completed1
Countries1
Therapeutic footprint
alzheimersdepressionepilepsyintellectual_disabilitystroke
Indexed studies
NCT03652246Evaluation of the Diagnostic Contribution of High-throughput Exome Sequencing for Patients With Convulsive Encephalopathy of Unknown Etiology: Pilot Study to Improve Genetic Counselling
epilepsy · FranceCOMPLETED
epilepsy · FranceCOMPLETED
NCT05683873Stroke-induced Myocardial Dysfunction: Role of GDF-15 (SMOG-15) Clinical Work Package
stroke · FranceNA
stroke · FranceNA
NCT02042573Preliminary Study to Investigate the Effect of rTMS and SSRI Antidepressants on Leukocyte Expression of the C-FOS and DUSP1 Genes in Patients Treated for Depression
depression · FrancePHASE4
depression · FrancePHASE4
NCT07686653A Study of the Value of Trio Genome Sequencing in the Etiological Evaluation of Early-Onset and/or Atypical Psychiatric Disorders Without Intellectual Disability or Congenital Anomalies
intellectual_disability · FranceNOT_YET_RECRUITING
intellectual_disability · FranceNOT_YET_RECRUITING
NCT05888961Single-center Prospective Longitudinal Study of Taste in Patients With Cognitive Disorders at Different Stages of Severity (Isolated Cognitive Complaint, Minor or Major Neurocognitive Alzheimer-type Disorders) by Analysis of Gustatory Evoked Potentials
alzheimers · FranceNA
alzheimers · FranceNA
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →